Calyxo Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
321
- Latest Deal Type
-
Series F
- Latest Deal Amount
-
$40.1M
- Investors
-
7
Calyxo General Information
Description
Developer of minimally invasive medical devices designed to improve kidney stone treatment outcomes. The company offers a ureteroscopy-based system with integrated laser lithotripsy for stone fragmentation, continuous irrigation for visualization and procedural control, dynamic aspiration for active removal of stone fragments and debris, and stone collection capabilities to ensure complete extraction, enabling urologists and healthcare providers to achieve stone clearance rates, reduce residual fragments, and improve overall patient outcomes in kidney stone treatment.
Contact Information
Website
www.calyxoinc.comCorporate Office
- 4473 Willow Road
- Suite 100
- Pleasanton, CA 94588
- United States
Corporate Office
- 4473 Willow Road
- Suite 100
- Pleasanton, CA 94588
- United States
Calyxo Timeline
Calyxo Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC (Series F) | 01-Apr-2026 | $40.1M | Completed | Generating Revenue | ||
| 6. Later Stage VC (Series E) | 26-Dec-2024 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series D) | 02-Nov-2023 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series C) | 06-Jul-2022 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series B) | 11-Oct-2019 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 16-Aug-2018 | $1.6M | $1.65M | Completed | Generating Revenue | |
| 1. Seed Round | 29-Mar-2016 | $50K | $50K | Completed | Startup |
Calyxo Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series F | ||||||||
| Series E | ||||||||
| Series D | ||||||||
| Series C | ||||||||
| Series B | ||||||||
| Series A | 2,245,290 | $0.001000 | 6% | $0.8 | $0.8 | 1x | $0.8 | 2.89% |
| Seed | 1,000,000 | $0.001000 | 6% | $0.25 | $0.25 | 1x | $0.25 | 1.29% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Calyxo Comparisons
Industry
Financing
Details
Calyxo Competitors (4)
One of Calyxo’s 4 competitors is Sonomotion, a Venture Capital-Backed company based in San Mateo, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Sonomotion | Venture Capital-Backed | San Mateo, CA | ||||
| Avvio Medical | Venture Capital-Backed | San Francisco, CA | ||||
| Dornier MedTech | Corporation | Weßling, Germany | ||||
| Lumenis | Private Equity-Backed | Yokneam, Israel |
Calyxo Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Calyxo Patents
Calyxo Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026064328-A1 | Catheter steering systems with an overcenter assist mechanism and a locking mechanism | Pending | 17-Sep-2024 | ||
| US-20250268614-A1 | System and method for detecting and preventing organ collapse during endoscopy | Pending | 23-Feb-2024 | ||
| US-12256989-B2 | Tool guiding device for kidney stone treatment apparatus | Active | 29-Sep-2022 | ||
| US-20240108412-A1 | Tool guiding device for kidney stone treatment apparatus | Pending | 29-Sep-2022 | ||
| US-20240341848-A1 | Tool guiding device for kidney stone treatment apparatus | Pending | 29-Sep-2022 | A61B18/26 |
Calyxo Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Calyxo Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ally Bridge Group | Growth/Expansion | Minority | ||
| Janus Henderson Investors | Asset Manager | Minority | ||
| Warren Point Capital | Venture Capital | Minority | ||
| Avidity Partners | Asset Manager | Minority | ||
| CRG | Lender/Debt Provider | Minority |
Calyxo FAQs
-
When was Calyxo founded?
Calyxo was founded in 2016.
-
Where is Calyxo headquartered?
Calyxo is headquartered in Pleasanton, CA.
-
What is the size of Calyxo?
Calyxo has 321 total employees.
-
What industry is Calyxo in?
Calyxo’s primary industry is Surgical Devices.
-
Is Calyxo a private or public company?
Calyxo is a Private company.
-
What is the current valuation of Calyxo?
The current valuation of Calyxo is .
-
What is Calyxo’s current revenue?
The current revenue for Calyxo is .
-
How much funding has Calyxo raised over time?
Calyxo has raised $166M.
-
Who are Calyxo’s investors?
Ally Bridge Group, Janus Henderson Investors, Warren Point Capital, Avidity Partners, and CRG are 5 of 7 investors who have invested in Calyxo.
-
Who are Calyxo’s competitors?
Sonomotion, Avvio Medical, Dornier MedTech, and Lumenis are competitors of Calyxo.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
